Affin Hwang maintains hold on IHH Healthcare, trims target to RM6.56


AmInvestment has a fair value of RM7.20 a share for IHH Healthcare Bhd

KUALA LUMPUR: Affin Hwang Capital Research is positive on IHH Healthcare Bhd’s venture into new markets.

However, the research house said IHH’s near-term earnings could be dampened by losses from the opening of new hospitals and hiccups from consolidation of newly-acquired entities.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Bursa Malaysia-Teraju team up to boost Bumiputera IPO participation
Dayang records higher 4Q net profit
Dialog continues positive turnaround
Heineken Malaysia delivers steady FY25 earnings
Toll highway segment drives Taliworks’ 4Q revenue
CPO futures likely to trade between RM3,800-RM4,000 per tonne until July 2026
Carlsberg Malaysia posts record net profit of RM376mil in FY25
Perdana Petroleum posts lower net profit of RM56.09mil in FY25
Pos Malaysia welcomes MyCC review, flags competition concerns
INSKEN leverages AI to empower entrepreneurs in high-value sectors

Others Also Read